Dr. Pablo Lores Lareo, PhDCMC Director at SylentisSpeaker
Profile
CMC Director at Sylentis, a leading CDMO specializing in the development and manufacturing of therapeutic oligonucleotides. I bring extensive experience in analytical development, GMP manufacturing, and regulatory strategy for innovative oligonucleotide-based therapies.
Agenda Sessions
Phase- appropriate CMC Considerations for Next-generation Oligonucleotides
, 11:15amView SessionLessons Learned Building an Oligo CMC Program for a Small Company: Doing More with Less
, 4:45pmView Session